Gender Differences & MS
RealTalk MS17 Heinä 2018

Gender Differences & MS

My guest this week is Dr. Rhonda Voskuhl, Director of the Multiple Sclerosis Program at the David Geffen School of Medicine at UCLA and the Jack H. Skirball professor of Multiple Sclerosis Research. Dr. Voskuhl is responsible for first identifying that understanding the gender differences in the disease is an important part of understanding MS. This is one of my favorite interviews, and it's packed with great information.

We're also talking about the potential of data and technology to improve care for people living with MS, how MS and depression can lead to high rates of Alexithymia among people living with MS, how recognizing non-traditional MS symptoms can lead to getting an MS diagnosis years earlier, and an opportunity for African-Americans with MS to participate in a UCSF study.

We have a lot to talk about! Are you ready for RealTalk MS?

____________

MS + Depression or Anxiety = High Rates of Alexithymia 2:04

MS Society U.K. Commissions Report on the Potential of Data and Technology to Improve Care for People Living with MS 4:13

U.K.'s National Health Service Announces New App 9:18

Recognizing Non-Traditional Symptoms Can Lead to MS Diagnosis Years Earlier 11:34

UCSF Recruiting African-Americans with MS for Study 14:24

Interview with Dr. Rhonda Voskuhl 17:01

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

International Progressive MS Alliance

High Levels of Alexithymia in Patients with Multiple Sclerosis

Improving Care for People with MS: The Potential of Data & Technology

New NHS App Will Make It Quciker & Easier to Access Health Services

Five Years Before MS Onset: Phenotyping the Prodrome

Email Address for UCSF Study is msdb@ucsf.edu

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 44
Hosted By: Jon Strum
Guest: Dr. Rhonda Voskuhl

Tags: MS, MultipleSclerosis, MSResearch, ProgressiveMS, mssocietyuk, UCLANeurology, UCSFMedicine, RealTalkMS

Jaksot(504)

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Welcome back to Part Two of our coverage of the 2026 ACTRIMS Forum. This week, we shift our focus to emerging therapies and clinical insights that are re-shaping the future of MS care. From the latest...

16 Helmi 44min

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the A...

9 Helmi 33min

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investig...

2 Helmi 39min

Episode 439: Preventing MS with Dr. Bruce Bebo

Episode 439: Preventing MS with Dr. Bruce Bebo

The first coordinated global research strategy to prevent MS has been announced. This week, Dr. Bruce Bebo, the National MS Society's Executive Vice President and Chief Research & Medical Affairs Offi...

26 Tammi 32min

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

One of the more confusing aspects of MS is that it can present differently from one person to the next. A research team at University College London may have uncovered a reason for that when they iden...

19 Tammi 29min

Episode 437: Remembering David Mitchell

Episode 437: Remembering David Mitchell

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medicati...

12 Tammi 29min

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Scientists are expanding our understanding of MS at an unprecedented pace. This week, Dr. Leorah Freeman discusses why, as new discoveries and medications enter clinical practice, neurologists and MS ...

5 Tammi 34min

Episode 435: Revisiting ECTRIMS 2025 with Dr. Bruce Bebo and Kristine Werner Ozug

Episode 435: Revisiting ECTRIMS 2025 with Dr. Bruce Bebo and Kristine Werner Ozug

We're closing out the year by revisiting the most listened-to episode of RealTalk MS in 2025. And it shouldn't come as a major surprise that this year's most listened-to episode was our review of the ...

29 Joulu 202524min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
psykopodiaa-podcast
rss-pitaisko-erota
puhu-muru
katilon-kahvitunti
terapiassa
rss-uplevel-by-sonja-hannus
rss-rakas-mielenterveyteni
rss-narsisti
selviytyjat-tarinoita-elamasta
junnut-pelissa
rss-duodecim-lehti
meditaatiot-suomeksi
audio-sport-juoksu
rss-pt-paahtio
rss-addiktit
rss-vapaudu-voimaasi